Can a urine culture and antimicrobial susceptibility test be performed while the patient is currently taking nitrofurantoin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Run a Urine Culture While on Nitrofurantoin?

Yes, you can and should obtain a urine culture and susceptibility test while the patient is actively taking nitrofurantoin—the presence of the antibiotic does not invalidate the culture, and obtaining pre-treatment cultures is mandatory for guiding targeted therapy in complicated UTIs.

Why Pre-Treatment Cultures Are Essential

  • Urine culture with susceptibility testing must be obtained before starting antimicrobial therapy (or as soon as possible if already started) to enable targeted treatment, because complicated UTIs exhibit a broader microbial spectrum and markedly higher antimicrobial resistance rates compared to uncomplicated infections. 1

  • The appropriate screening and diagnostic test for bacteriuria is a urine culture, not dipstick urinalysis or pyuria screening, which have insufficient sensitivity and specificity for guiding antibiotic selection. 2

  • Bacteriuria is more specific and sensitive than pyuria for detecting urinary tract infection, even in older women and during pregnancy, making culture the gold standard regardless of concurrent antibiotic exposure. 3

Impact of Nitrofurantoin on Culture Results

  • Nitrofurantoin does not sterilize urine rapidly enough to prevent pathogen recovery in most cases—studies demonstrate that bacteriuria remains detectable in 65% of samples even during active nitrofurantoin prophylaxis, confirming that cultures can still yield diagnostic information. 4

  • The bacterial species responsible for bacteriuria may be altered during nitrofurantoin therapy, with Escherichia coli being replaced by resistant Klebsiella spp. and Pseudomonas spp., making culture even more critical to identify emerging resistant organisms. 4

  • Nitrofurantoin achieves high urinary concentrations but low serum levels, meaning its bactericidal activity is site-specific to the urinary tract; however, this does not prevent laboratory recovery of organisms from properly collected specimens. 5

Clinical Implications for Culture Timing

  • Do not delay obtaining a urine culture because the patient is already on antibiotics—the culture should be drawn immediately, as even partial antibiotic exposure provides valuable susceptibility data and may reveal treatment failure or resistant organisms. 1

  • For catheter-associated UTIs, replace indwelling catheters that have been in place for ≥2 weeks at the onset of infection, and obtain the culture from the newly placed catheter prior to (or concurrent with) antibiotic initiation to maximize diagnostic yield. 1

  • In patients with recurrent UTIs or complicated infections, urine culture is mandatory even if empiric therapy has been started, because resistance patterns vary widely and culture-guided therapy is essential for optimal outcomes. 1

Special Considerations for Nitrofurantoin

  • Nitrofurantoin is contraindicated for complicated UTIs or when upper-tract involvement is suspected because of insufficient tissue penetration and lack of efficacy data, so if a culture is being obtained for a complicated infection, the patient should likely be transitioned to a more appropriate agent based on culture results. 1

  • Nitrofurantoin should not be used when eGFR <30 mL/min, as it fails to achieve therapeutic urinary concentrations and carries a risk of peripheral neuritis, making culture results even more critical to guide alternative therapy selection. 1

References

Guideline

Complicated Urinary Tract Infections Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and treatment of urinary tract infections across age groups.

American journal of obstetrics and gynecology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.